21 completed, 3 recruiting, 1 terminated, 1 withdrawn. 14 Phase 4, 5 Phase 3, 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Completed 13, Withdrawn 1 |
| Phase 3 | 5 | Completed 3, Recruiting 1, Terminated 1 |
| Phase 2 | 4 | Completed 2, Recruiting 2 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow mycophenolate sodium: new trials by email Literature Review of mycophenolate sodium trials Research Report on mycophenolate sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation Frexalimab, Tacrolimus, rabbit anti-thymocyte globulin - Kidney Transplant Rejection | Phase 2 / Phase 3 | Recruiting | Sanofi | 526 | 2026-03-13 | 2026-10-13 |
| Effect of Azole/Echinocandin Use on Tacrolimus Pharmacokinetics Combined with voriconazole, Combined with caspofungin, Tacrolimus-alone treatment - Kidney Transplant Patients | Completed | LI YAN | 507 | 2022-09-01 | 2023-09-28 | |
| Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis Myfortic - Lupus Nephritis | Completed | Novartis Pharmaceuticals | 69 | 2021-03-16 | 2026-06-30 | |
| Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cyclosporine - Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 60 | 2021-01-25 | 2026-05-29 |
| CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia Cladribine, Cyclophosphamide, Cyclosporine - Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia | Phase 1 | Recruiting | Fred Hutchinson Cancer Center | 120 | 2020-12-03 | 2026-09-17 |
| Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation Sirolimus, Everolimus, Mycophenolic acid - Kidney Transplant Infection | Phase 4 | Completed | Hospital do Rim e Hipertensão | 1209 | 2017-06-18 | 2023-04-24 |
| Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients Tacrolimus Extended Release Capsule, Mycophenolate mofetil, Prednisone - Immunosuppression | Phase 4 | Completed | Medical University of South Carolina | 25 | 2017-05-05 | 2019-12-26 |
| Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function Everolimus, Tacrolimus, Mycophenolate sodium - Chronic Kidney Disease | Phase 3 | Completed | Poitiers University Hospital | 329 | 2014-12-11 | 2021-01-29 |
| Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring Myfortic®, Neoral®, Cellcept® - Cardiovascular Disease, Cardiovascular Outcomes | Phase 4 | Withdrawn | University of Saskatchewan | 2014-02-01 | 2017-01-09 | |
| Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients sirolimus, tacrolimus, mycophenolate - Disorder Related to Renal Transplantation, Cytomegalovirus Infections | Phase 4 | Completed | Associação Médico Espírita de Botucatu | 48 | 2014-01-01 | 2016-02-17 |
| A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) Mycophenolate sodium, Mycophenolate mofetil - Renal Transplantation | Phase 4 | Completed | Irmandade Santa Casa de Misericórdia de Porto Alegre | 100 | 2013-04-01 | 2015-04-03 |
| Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study) Simulect®, Neoral®, Certican® - Renal Transplantation | Phase 2 | Completed | Novartis Pharmaceuticals | 16 | 2012-03-01 | 2014-07-25 |
| Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS Mycophenolate sodium, Pantoprazole, Mycophenolate mofetil - Transplantation, Immunosuppression | Phase 4 | Completed | Klemens Budde | 20 | 2012-01-01 | 2019-02-21 |
| Everolimus in de Novo Kidney Transplant Recipients Everolimus, Mycophenolate sodium, Cyclosporine - Kidney Transplantation | Phase 3 | Completed | Novartis Pharmaceuticals | 383 | 2011-11-01 | 2017-06-16 |
| Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate Thymoglobulin, Everolimus, Basiliximabe - Cytomegalovirus Infection, Renal Transplant Failure | Phase 4 | Completed | Hospital do Rim e Hipertensão | 300 | 2011-05-01 | 2015-03-23 |
| Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation Basiliximab, Tacrolimus, Mycophenolic Acid - Liver Transplantation | Phase 4 | Completed | University of California, Los Angeles | 59 | 2011-01-01 | 2022-09-29 |
| Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study Myfortic plus low-dose steroid, Prednisolone - Nephrosis, Lipoid | Phase 4 | Completed | The University of Hong Kong | 20 | 2010-09-01 | 2018-06-01 |
| Myfortic for the Treatment of Non-infectious Intermediate Uveitis Myfortic, Decortin - Uveitis, Intermediate | Phase 3 | Completed | STZ eyetrial | 44 | 2010-03-01 | 2017-05-09 |
| The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis mycophenolate sodium, cyclophosphamide - Lupus Nephritis | Phase 3 | Terminated | Chulalongkorn University | 59 | 2010-01-01 | 2014-10-10 |
| A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients MMF, EC-MPS, Prednisone - Kidney Transplantation | Phase 4 | Completed | Hoffmann-La Roche | 23 | 2009-11-01 | 2015-08-27 |
Showing 20 of 26. Sign in to see all of them.
Lupus Nephritis (3) · Cytomegalovirus Infections (2) · Leukemia, Biphenotypic, Acute (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Chronic (2) · Myelodysplastic Syndromes (2) · Burkitt Lymphoma (1) · Cardiovascular Diseases (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Prolymphocytic (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1)
Novartis Pharmaceuticals (4) · Fred Hutchinson Cancer Center (2) · Hospital do Rim e Hipertensão (2) · Associação Médico Espírita de Botucatu (1) · Astellas Pharma Inc (1) · Cedars-Sinai Medical Center (1) · Chulalongkorn University (1) · Hoffmann-La Roche (1) · Irmandade Santa Casa de Misericórdia de Porto Alegre (1) · Klemens Budde (1) · LI YAN (1) · Medical University of South Carolina (1) · Novartis (1) · Poitiers University Hospital (1) · STZ eyetrial (1)
United States (7) · Brazil (5) · Germany (5) · France (4) · China (3) · Italy (3) · Taiwan (3) · Hungary (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Belgium (1) · Canada (1) · Chile (1)
Ahmed Shoker, MD (1) · Bruna Cardoso, Pharmacist (1) · Christoph Deuter, Dr. (1) · Daniela Seelig, Physician (1) · Elizete Keitel, Physician (1) · Ernst Schwarz, MD (1) · Fabiano Klaus, Physician (1) · Fady M Kaldas, MD (1) · Filippo Milano (1) · Fuad Shihab, MD (1) · Helen Zanetti, Pharmacist (1)
PMID 25988935, PMID 26369526, PMID 26398638, PMID 26835147, PMID 31769845, PMID 33988338, PMID 35230699, PMID 37525373
2009 (2), 2025 (1), P30CA015704 (1)